Animal Models of Parkinson's Disease 2012

Animal Models of Parkinson's Disease 2012

Saved in:

Bibliographic Details
Main Authors:	Yuzuru Imai, Katerina Venderova, Kah-Leong Lim
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Parkinson's Disease
Online Access:	http://dx.doi.org/10.1155/2012/729428
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Animal Models of Parkinson's Disease
by: Yuzuru Imai, et al.
Published: (2011-01-01)

Limitations of Animal Models of Parkinson's Disease
by: J. A. Potashkin, et al.
Published: (2011-01-01)

Lipopolysaccharide Animal Models for Parkinson's Disease
by: Mei Liu, et al.
Published: (2011-01-01)

Mycobacterial Diseases of Animals 2012
by: Mitchell V. Palmer, et al.
Published: (2012-01-01)

The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson’s Disease
by: Minrui Weng, et al.
Published: (2018-01-01)

Toxin-Induced and Genetic Animal Models of Parkinson's Disease
by: Shin Hisahara, et al.
Published: (2011-01-01)

Therapeutic Effects of Hydrogen in Animal Models of Parkinson's Disease
by: Kyota Fujita, et al.
Published: (2011-01-01)

Imaging advances to detect non-motor prodromal markers of Parkinson’s disease and explore therapeutic translation opportunities
by: Mathangi Palanivel, et al.
Published: (2025-06-01)

Leveraging animal models to understand non-motor symptoms of Parkinson's disease
by: Thomas Wichmann, et al.
Published: (2025-05-01)

Model-Based Feature Extraction and Classification for Parkinson Disease Screening Using Gait Analysis: Development and Validation Study
by: Ming De Lim, et al.
Published: (2025-04-01)

PAIN IN A PARKINSON`S DISEASE RODENT ANIMAL MODEL INDUCED WITH 6-HYDROXYDOPAMINE
by: Antioch, I, et al.
Published: (2017-06-01)

SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models
by: Oh‐Chan Kwon, et al.
Published: (2021-03-01)

Impulsivity in Patients with Parkinson’s Disease
by: Rumyana Kuzmanova, et al.
Published: (2017-11-01)

Neuroprotective effects of essential oils in animal models of Alzheimer’s and Parkinson’s disease: a systematic review
by: Adrielle do Espírito Santos Macedo, et al.
Published: (2025-07-01)

Effects of SR141716A on Cognitive and Depression-Related Behavior in an Animal Model of Premotor Parkinson's Disease
by: M. T. Tadaiesky, et al.
Published: (2010-01-01)

Application of neurotoxin- and pesticide-induced animal models of Parkinson’s disease in the evaluation of new drug delivery systems
by: Casanova Yaquelyn, et al.
Published: (2022-03-01)

ZSCAN21 mediates the pathogenic transcriptional induction of α-synuclein in cellular and animal models of Parkinson’s disease
by: Alina Kozoriz, et al.
Published: (2025-05-01)

Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence
by: A. Machado, et al.
Published: (2011-01-01)

LRRK2G2019S Gene Mutation Causes Skeletal Muscle Impairment in Animal Model of Parkinson's Disease
by: Yiying Hu, et al.
Published: (2024-12-01)

Effect of Swimming Training with Hesperidin on Gene Expression Related Dopaminergic Neuron Survival in an Animal Model of Parkinson\'s Disease
by: Asma Taraz, et al.
Published: (2025-08-01)

Appendectomy and risk of Parkinson’s disease: a systematic review and meta-analysis
by: Hok Leong Chin, et al.
Published: (2025-07-01)

LIVESTOCK DECLINE AND ANIMAL OUTPUT GROWTH IN THE EUROPEAN UNION IN THE PERIOD 2012-2021
by: Agatha POPESCU, et al.
Published: (2022-01-01)

Epidemiology of Tularemia among Humans and Animals, Baden-Wuerttemberg, Germany, 2012–2022
by: Sabrina Nothdurfter, et al.
Published: (2025-04-01)

Vagus nerve stimulation in Parkinson’s disease: a scoping review of animal studies and human subjects research
by: Alexandra Evancho, et al.
Published: (2024-10-01)

Brooks, David. The Social Animal. New York: Random House, 2012. 382 pp.
by: Rodrigo Mora
Published: (2013-01-01)

Parkinson's Disease
by: Flavio Fröhlich
Published: (2018-08-01)

Metallothionein II treatment mitigates rotenone-induced neurodegeneration in zebrafish models of Parkinson’s disease
by: Yong Hui Nies, et al.
Published: (2025-01-01)

Prodromal Parkinson’s disease and subsequent risk of Parkinson’s disease and mortality
by: Xiao Chen, et al.
Published: (2025-01-01)

Animal models of oral infectious diseases
by: Jing Li, et al.
Published: (2025-04-01)

Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease
by: Hanjiang Luo, et al.
Published: (2026-04-01)

Psychological Benefits of Nonpharmacological Methods Aimed for Improving Balance in Parkinson’s Disease: A Systematic Review
by: Rastislav Šumec, et al.
Published: (2015-01-01)

Risk factors for falls in Parkinson's disease and other parkinsonisms
by: Aleksandra Buczek, et al.
Published: (2024-12-01)

Physiotherapy in Parkinson’s Disease: Building ParkinsonNet in Czechia
by: Ota Gal, et al.
Published: (2017-01-01)

From the baker to the bedside: yeast models of Parkinson's disease
by: Regina Menezes, et al.
Published: (2015-07-01)

Prevalence of Cysticercus bovis and Sarcocystis spp. infection in slaughtered animals in Khorramabad abattoir from 2012 to 2021
by: Azadeh Rashidimehr, et al.
Published: (2024-12-01)

Spontaneous eye blink-based machine learning for tracking clinical fluctuations in Parkinson’s disease
by: Noriko Nishikawa, et al.
Published: (2025-08-01)

Animal Models of Calcific Aortic Valve Disease
by: Krista L. Sider, et al.
Published: (2011-01-01)

Animal Models of Diabetes and Metabolic Disease 2014
by: Tomohiko Sasase, et al.
Published: (2015-01-01)

Parkinson’s Disease and Autophagy
by: Ana María Sánchez-Pérez, et al.
Published: (2012-01-01)

Methamphetamine and Parkinson's Disease
by: Noelia Granado, et al.
Published: (2013-01-01)